2,3-DIHYDRO-4H-1,3-BENZOXAZIN-4-ONE DERIVATIVES AS MODULATORS OF CHOLINERGIC MUSCARINIC M1 RECEPTOR

• 收藏
• 分享

专利权人:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

发明人:

KAMATA, Makoto,KIMURA, Eiji,KOJIMA, Takuto,MURAKAMI, Masataka,NAKAMURA, Minoru,OGINO, Masaki,SAKAMOTO, Hiroki,SHIMOKAWA, Kenichiro,SUGIMOTO, Takahiro,SUZUKI, Shinkichi,YAMADA, Masami,YONEMORI, Jinichi

申请号：

TN2017000508

公开号：

TN2017000508A1

申请日:

2016.06.23

申请国别(地区):

TN

年份:

2019

代理人:

摘要：

The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/